Abiopharma

News list

Quinn Sean Edward 🟢 acquired 59.2K shares (1 derivative) of CIMPRESS plc (CMPR) Transaction Date: Aug 07, 2026 | Filing ID: 000008

Full text

News bot Aug. 11, 2026, 8:19 p.m.
🔍 Quinn Sean Edward (Executive)

Company: CIMPRESS plc (CMPR)

Report Date: 2026-08-07
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 59,194
Detailed Transactions and Holdings:
- Acquired 59,194 shares of Performance Share Units (Derivative)
  Date: 2026-08-07 | Code: A | Expires: 2029-08-15 | Exercise: 2026-08-15 | equity_swap_involved: 0 | shares_owned_after: 59,194.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Performance share unit (PSU) award granted on August 15, 2025 with performance conditions based on adjusted EBITDA and variable gross profit of Cimpress plc for the fiscal year ended June 30, 2026. On August 7, 2026, Cimpress' Compensation Committee determined the number of shares issuable pursuant to this PSU award based on the level of achievement against the performance conditions, with each PSU representing Cimpress' commitment to issue one ordinary share.
- F2: These PSUs vest over the following four-year period: 25% of the number of shares determined to be issuable vest on the Date Exercisable shown in Table II and 6.25% of such number of shares vest quarterly thereafter.